Gardner Lewis Asset Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Gardner Lewis Asset Management’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,084,858	Closed	-$22.7M	–	143
2016 Q3	$22.7M	Buy	+1,084,858	New	+$12.5M	1.84%	16

Gardner Lewis Asset Management's VTAE Position: Q4 2016 in Review

Gardner Lewis Asset Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 1,084,858 shares — an estimated $22.7M sold.

Gardner Lewis Asset Management first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $22.7M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Gardner Lewis Asset Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Gardner Lewis Asset Management sold 1,084,858 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $22.7M.
Gardner Lewis Asset Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Gardner Lewis Asset Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $22.7M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.